Acquired Orphan Blood Disease Market Research Reveals Rapid Growth in Asia and Innovative Therapies
25 janv. 2024 05h39 HE
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Acquired Orphan Blood Disease Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade,...
Global Hematology Analyzer Markets Report 2023: 2020-2023 Data & CAGR Projections Through 2028
21 juin 2023 07h48 HE
|
Research and Markets
Dublin, June 21, 2023 (GLOBE NEWSWIRE) -- The "Hematology Analyzer Market" report has been added to ResearchAndMarkets.com's offering.The global market for hematology analyzers was valued at $3.8...
Acquired Orphan Blood Disease Market reach a growth of US$ 21.5 Bn by 2032 – Persistence Market Research
20 oct. 2022 10h00 HE
|
Persistence Market Research
New York, Oct. 20, 2022 (GLOBE NEWSWIRE) -- The global acquired orphan blood disease market is estimated to expand at a CAGR of 10.4% and value of US$ 21.5 Bn by 2032, up from US$ 8 Bn in 2022....
Global Cord Blood Banking Services Market Is Expected to Reach $4.5 Billion by 2030: AMR
27 avr. 2022 06h42 HE
|
Allied Market Research
Portland, OR, April 27, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Cord Blood Banking Services Market generated $1.3 billion in 2020, and is...
Worldwide Hematology Analyzers and Reagents Industry to 2027 - Increasing Incidence of Hematologic Diseases is Driving Growth
31 août 2021 04h18 HE
|
Research and Markets
Dublin, Aug. 31, 2021 (GLOBE NEWSWIRE) -- The "Hematology Analyzers and Reagents Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product and Service; Application; End User, and...
Imara Announces Recipients of the Second Annual Real Impact Grants Program to Support People Affected by Rare Genetic Blood Disorders
17 juin 2021 07h00 HE
|
Imara, Inc.
BOSTON, June 17, 2021 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients...